Transgenomic Stockholders and Precipio Diagnostics Members Approve Merger

08:25 EDT 6 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Transgenomic, Inc. (OTCBB: TBIO) today announced that its stockholders have approved the merger with Precipio Diagnostics, LLC. Upon completion of the merger, the company expects to meet the requirements for its stock to be reli...

Other Sources for this Article

Transgenomic Media:
BLL Partners
Barbara Lindheim, 212-584-2276
Transgenomic Investors
Transgenomic Investor Relations


More From BioPortfolio on "Transgenomic Stockholders and Precipio Diagnostics Members Approve Merger"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...